Financials data is unavailable for this security.
View more
Year on year Escalon Medical Corp grew revenues 13.80% from 10.70m to 12.18m. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 2,426.71% net income growth from 18.08k to 456.83k.
Gross margin | 44.07% |
---|---|
Net profit margin | -0.53% |
Operating margin | -0.33% |
Return on assets | -1.26% |
---|---|
Return on equity | -27.97% |
Return on investment | -2.84% |
More ▼
Cash flow in USDView more
In 2023, Escalon Medical Corp increased its cash reserves by 34.82%, or 295.94k. The company earned 325.15k from its operations for a Cash Flow Margin of 2.67%. In addition the company used 13.84k on investing activities and also paid 15.37k in financing cash flows.
Cash flow per share | -0.0288 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2259 |
---|---|
Tangible book value per share | 0.2186 |
More ▼
Balance sheet in USDView more
Current ratio | 1.58 |
---|---|
Quick ratio | 0.8927 |
Total debt/total equity | 0.1882 |
---|---|
Total debt/total capital | 0.1584 |
More ▼